Some experimental data suggest that lower methylation levels and less restriction of the TNF‐α promoter in the brains of AD patients lead to elevated levels of TNF‐α expression, which may contribute to the pathogenesis of AD.60, 61. Here, TNF is linked to Alzheimer disease.